Creative and courageous Community Fundraisers
The creative ways our dedicated community fundraise for MIA never ceases to amaze us! We are so appreciative of their efforts, which help fund our life-saving research.
The creative ways our dedicated community fundraise for MIA never ceases to amaze us! We are so appreciative of their efforts, which help fund our life-saving research.
MIA urges workplaces to enforce sun safe practices this National Safe Work Month, with Speakers' Hub presenter Andrew Camfield sharing his story with 400 Blacktown City Council tradies.
We were delighted to have the honour of meeting with His Majesty King Charles III this week, a once-in-a-lifetime opportunity to shine an international spotlight on melanoma.
This World Cancer Research Day, the NSW Government is committing $2.1 million in research grant funding, with almost $700k awarded to MIA's Prof Long for an imaging system that will allow researchers to better visualise & understand tumour cell interactions.
MIA’s leading experts and early career researchers have shared the world stage at the annual European Society for Medical Oncology (ESMO) Congress in Barcelona.
We are so grateful for the efforts of our 'Melanoma Heroes' - all those in our community who have contributed to MIA fundraising to support our research and patient support services. Find out more about how to get involved!
A/Prof Serigne Lo leads a team responsible for the design & analysis of clinical trials, and the development of tools that guide the treatment of melanoma patients. Let's dive into his life and research!
MIA, alongside ACEMID, hosted an important melanoma data workshop in Sydney, to prepare for the massive volumes of data that will help create the evidence for a national targeted melanoma-screening program.
Australians are being urged to take sun safety seriously as the weather warms up, with Bondi Rescue star Tommy Woodriff sharing his skin cancer risk as a warning to others.
Meet Dr Jordan Conway, whose crucial research focuses on melanoma metastases in the liver, neoadjuvant immunotherapy and strategies to overcome treatment resistance.